U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.28G>A (p.Val10Ile) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Oct 1, 2020
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000235217.15

Allele description [Variation Report for NM_000546.6(TP53):c.28G>A (p.Val10Ile)]

NM_000546.6(TP53):c.28G>A (p.Val10Ile)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.28G>A (p.Val10Ile)
Other names:
p.V10I:GTC>ATC
HGVS:
  • NC_000017.11:g.7676567C>T
  • NG_017013.2:g.15984G>A
  • NM_000546.6:c.28G>AMANE SELECT
  • NM_001126112.3:c.28G>A
  • NM_001126113.3:c.28G>A
  • NM_001126114.3:c.28G>A
  • NM_001126118.2:c.-207G>A
  • NM_001276695.3:c.-90G>A
  • NM_001276696.3:c.-90G>A
  • NM_001276760.3:c.-90G>A
  • NM_001276761.3:c.-90G>A
  • NP_000537.3:p.Val10Ile
  • NP_000537.3:p.Val10Ile
  • NP_001119584.1:p.Val10Ile
  • NP_001119585.1:p.Val10Ile
  • NP_001119586.1:p.Val10Ile
  • LRG_321t1:c.28G>A
  • LRG_321:g.15984G>A
  • LRG_321p1:p.Val10Ile
  • NC_000017.10:g.7579885C>T
  • NM_000546.4:c.28G>A
  • NM_000546.5(TP53):c.28G>A
  • NM_000546.5:c.28G>A
  • P04637:p.Val10Ile
  • p.V10I
Protein change:
V10I
Links:
UniProtKB: P04637#VAR_044546; dbSNP: rs535274413
NCBI 1000 Genomes Browser:
rs535274413
Molecular consequence:
  • NM_001126118.2:c.-207G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001276695.3:c.-90G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001276696.3:c.-90G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001276760.3:c.-90G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001276761.3:c.-90G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000546.6:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.28G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000149626GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely benign
(Oct 1, 2020)
germlineclinical testing

Citation Link,

SCV000884715ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Uncertain significance
(Jun 20, 2017)
germlineclinical testing

Citation Link,

SCV005218660Breakthrough Genomics, Breakthrough Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benigngermlinenot provided

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing, not provided
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneDx, SCV000149626.16

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19651601, 24811890, 25186627, 30287823, 30840781, 30224644, 33300245)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000884715.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The TP53 c.28G>A;p.Val10Ile variant has been shown to function similarly to wild type in at least some functional studies (Kato 2003, Shiraishi 2004). The variant is listed in the ClinVar database (Variation ID: 127806) and the dbSNP variant database (rs535274413) with an allele frequency of 0.003258 percent (8/245572 alleles) in the Genome Aggregation Database. The amino acid at this position is weakly conserved across species and computational algorithms (Align GVGD, PolyPhen2, SIFT) predict this variant is tolerated, although the amino acid is located in the transactivation domain (Bode 2004). Considering available information, there is insufficient evidence to classify the variant with certainty. If this variant is later determined to be pathogenic, this individual would be at increased risk for development of hereditary cancers (OMIM#191170). References: Bode AM and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004 Oct;4(10):793-805. Kato S et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Shiraishi K et al. Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem. 2004 Jan 2;279(1):348-55.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Breakthrough Genomics, Breakthrough Genomics, SCV005218660.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024